GlassScriptPhysician profile
David B Mishkin
NPI 1700896206
$23,814.23
in general payments reported to CMS, 2019-2025
49 companies · $791 in 2025
The $791 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $932 · 2021: $1,333 · 2022: $15K · 2023: $4,548 · 2024: $685 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,750 · Food and Beverage: $2,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,750.00 |
| Food and Beverage | $2,274.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viz.Ai, INC. | $13,731.25 | 2022 | |
| Meridian Bioscience INC. | $3,750.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $858.42 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $683.59 | 2019-2025 | Ozempic, Wegovy |
| Abbvie INC. | $598.75 | 2021-2024 | |
| Glaxosmithkline, LLC. | $596.39 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $552.20 | 2019-2025 | |
| Lilly USA, LLC | $392.47 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $286.10 | 2022-2024 | |
| Exact Sciences Corporation | $272.85 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $272.07 | 2020-2021 | |
| Amgen INC. | $196.65 | 2019-2025 | Otezla, Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $161.71 | 2020-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $108.84 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $101.04 | 2021-2022 |
Show all 42 companies
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mishkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.